Quarterly report pursuant to Section 13 or 15(d)

Condensed Interim Consolidated Balance Sheets

v3.19.2
Condensed Interim Consolidated Balance Sheets - USD ($)
May 31, 2019
Nov. 30, 2018
CURRENT ASSETS    
Cash and cash equivalents $ 738,714 $ 1,182,387
Accounts receivable 71,008 18,914
Inventory 587,476 129,121
Prepaid expenses and other receivables 807,232 901,247
Total Current Assets 2,204,430 2,231,669
Patent rights 102,668 106,334
Deposit for equipment 227,781 205,664
Property and equipment 247,404 113,418
TOTAL ASSETS 2,782,283 2,657,085
CURRENT LIABILITIES    
Accounts payable and accrued liabilities 928,103 397,309
Deferred revenue 38,776  
Secured convertible debentures   978,361
Convertible debentures 1,590,757  
Derivative liabilities 310,539 957,301
Total Current Liabilities 2,868,175 2,332,971
Long term convertible notes   167,077
Total Liabilities 2,868,175 2,500,048
Capital stock    
Preferred stock, $0.001 par value, 5,000,000 shares authorized, Nil issued and outstanding (November 30, 2018 - nil).
Common stock, $0.001 par value 300,000,000 shares authorized, 104,156,775 issued and outstanding (November 30, 2018: 101,976,900) 104,157 101,977
Additional paid-in capital 34,707,208 33,341,695
Shares to be issued 20,000  
Accumulated deficit (34,854,841) (33,252,338)
Accumulated other comprehensive loss (62,416) (34,297)
Total Stockholders' (Deficiency) Equity (85,892) 157,037
TOTAL LIABILITIES AND STOCKHOLDERS' (DEFICIENCY) EQUITY $ 2,782,283 $ 2,657,085